Other
Probiotics
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Probiotics is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
27
clinical trials
Completed18 · 67%
Unknown status6 · 22%
Recruiting2 · 7%
Not yet recruiting1 · 4%
Clinical Trials
Trial Activity
27 trials
The Effect of Probiotics ATG-F4 in Cancer Patients
Recruiting·—·Phase 2·NCT06436976·30 enrolled
The Effect of Probiotics on Gums Health and Bad Breath
Completed·—·N/A·NCT06910397·88 enrolled
Using Probiotics to Improve Oral Hygiene During Orthodontic Treatment
Completed·—·N/A·NCT06641960·50 enrolled
Validation of the In-utero Transmission of Probiotics
Completed·—·Phase 2·NCT04050189·52 enrolled
Investigating the Bactericidal Effect of Probiotics on Chromogenic Bacteria in Children An In Vivo and In Vitro Study
Completed·—·Phase 4·NCT06834815·9 enrolled
Effect of Probiotics on the Digestibility and Immunity in Infants
Completed·—·N/A·NCT02317406·133 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)